Development of novel virosome-based vaccines

Pevion Biotech is a company dedicated to creating novel virosome formulated vaccines and bringing them from research into clinical development. Pevion Biotech´s technology platforms make it possible to  formulate suitable antigens with virosomes and integrate them into a standardized vaccine development process. Appropriate resources (e.g. GMP pilot facility for production of virosome-formulated vaccines) provide the opportunity for an accelerated and product-orientated development through clinical phase I/II.

Pevion Biotech´s scientists are some of the most specialized in the field of virosomal technology. Additionally, the biocompatible nature of the virosome-based adjuvant/carrier system and the fact that it is already applied for human use in registered vaccines will significantly help to accelerate the clinical development of promising vaccine candidates.


For further information please download:

Candida Vaccine Fact Sheet

RSV Vaccine Fact Sheet

Broadband Influenza Vaccine Fact Sheet